This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks Investment Ideas feature highlights: Microsoft, Nvidia, Alphabet, Mobileye and Intuitive Surgical
by Zacks Equity Research
Microsoft, Nvidia, Alphabet, Mobileye and Intuitive Surgical are part of the Zacks Investment Ideas article.
Intuitive Surgical (ISRG) Falls Following Q4 Earnings Miss
by Zacks Equity Research
Intuitive Surgical's (ISRG) fourth-quarter results reflect healthy demand for procedures, partially offset by lower system sales and unfavorable currency. Procedure volume in China suffers.
The Coming AI Revolution: 5 Companies at the Forefront
by Andrew Rocco
Artificial intelligence has been catapulted into the mainstream after the successful launch of OpenAI's ChatGPT. Andrew Rocco breaks down 5 public companies leveraging AI technology to grow their business.
Compared to Estimates, Intuitive Surgical, Inc. (ISRG) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Intuitive Surgical, Inc. (ISRG) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Intuitive Surgical, Inc. (ISRG) Q4 Earnings Miss Estimates
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of -2.38% and 0%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Spectacular Earnings Charts
by Tracey Ryniec
These 5 companies have great earnings surprise track records but will it matter this week?
Intuitive Surgical, Inc. (ISRG) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $256.77, moving +1.69% from the previous trading session.
Intuitive Surgical (ISRG) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Intuitive Surgical's (ISRG) fourth-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs may have hurt margins.
Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $252.50 in the latest trading session, marking a -1.5% move from the prior day.
The Zacks Analyst Blog Highlights Pfizer, Abbott Laboratories, Union Pacific Corporation, Citigroup and Intuitive Surgical.
by Zacks Equity Research
Pfizer, Abbott Laboratories, Union Pacific Corporation, Citigroup and Intuitive Surgical are part of the Zacks top Analyst Blog.
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE
Top Analyst Reports for Pfizer, Abbott Laboratories & Union Pacific
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Abbott Laboratories (ABT) and Union Pacific Corporation (UNP).
Here's Why You Should Retain Intuitive Surgical (ISRG) Stock
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to gain traction from the increasing adoption of the da Vinci Surgical System. Improving margins buoy optimism.
Analysts Estimate Intuitive Surgical, Inc. (ISRG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Intuitive Surgical (ISRG) Reports Mixed Preliminary Q4 Revenues
by Zacks Equity Research
Intuitive Surgical's (ISRG) revenue growth in the fourth quarter is driven by increase in procedure volume, partially offset by resurgence of COVID-19 in China.
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $256.94 in the latest trading session, marking a -1.16% move from the prior day.
Company News for Jan 12, 2023
by Zacks Equity Research
Companies In The News Are: GS, ISRG, AAPL, AMC.
Why You Should Hold Elevance Health (ELV) in Your Portfolio
by Zacks Equity Research
Elevance Health (ELV) remains well-poised for growth due to a growing customer base within its Government and IngenioRx businesses coupled with solid cash-generating abilities.
Here's Why You Should Hold Cigna (CI) Stock in Your Portfolio
by Zacks Equity Research
Cigna (CI) remains well-poised for growth on the back of the solid Evernorth and Cigna Healthcare businesses, an expanding customer base and robust cash-generating abilities.
AngioDynamics (ANGO) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AngioDynamics (ANGO) delivered earnings and revenue surprises of 200% and 1.65%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $265.63, moving +0.11% from the previous trading session.
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.88%: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed at $261.65 in the latest trading session, marking a -0.88% move from the prior day.
Implied Volatility Surging for Intuitive Surgical (ISRG) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Intuitive Surgical (ISRG) stock based on the movements in the options market lately.
Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $261.80, moving +0.3% from the previous trading session.
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.39%: What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $280.65, moving -0.39% from the previous trading session.